Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2024-05-30
Product name:
SEAFORD NIFEDIPINE AND LIDOCAINE HYDROCHLORIDE CREAM
DIN:
02548283
Product Monograph/Veterinary Labelling:
Date:
2024-05-30
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SEAFORD PHARMACEUTICALS INC
UNIT 29
1530 Drew Road
Mississauga
Ontario
Canada
L5S 1W8
Class:
Human
Dosage form(s):
Cream
Route(s) of administration:
Rectal
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
72:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
C05AD01 LIDOCAINE
Active ingredient group (AIG) number:See footnote5
0265923001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE | 1.5 % / W/W |
| NIFEDIPINE | 0.3 % / W/W |